Successful treatment with antiprogrammed-death-1 antibody in a relapsed natural killer/T-cell lymphoma patient with multi-line resistance: A case report

Extranodal natural killer/T-cell lymphoma (NKTCL), nasal type, is an aggressive malignancy with poor prognosis. Currently, there is no recommended standard therapy for relapsed NKTCL.